Condition
Nightmares, REM-Sleep Type
Total Trials
7
Recruiting
0
Active
0
Completed
6
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 7 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 6 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
7Total
Not Applicable (7)
Trial Status
Completed6
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (7)
Showing 7 of 7 trials
NCT04040387Not ApplicableCompleted
NightWare Randomized Trial 02
NCT05933109Not ApplicableCompletedPrimary
Mental Imagery and Targeted Memory Reactivation in PTSD
NCT04776304Not ApplicableCompleted
Art Therapy QEEG Study for Service Members with a Traumatic Brain Injury and Posttraumatic Stress Symptoms
NCT05237778Not ApplicableCompletedPrimary
Combined Treatment of Nightmares With Targeted Memory Reactivation and Imagery Rehearsal Therapy
NCT03934658Not ApplicableCompleted
Remote Study of NightWare for PTSD With Nightmares
NCT03828656Not ApplicableUnknown
NightWare Open Enrollment Study
NCT03795987Not ApplicableCompleted
Traumatic Nightmares Treated by NightWare (To Arouse Not Awaken)
Showing all 7 trials